Portland Investment Counsel Inc.
Source: SEC Form 13F · as of Mar 2026Portland Investment Counsel Inc. holds 14 biotech & pharma companies tracked by BioSniper, totaling $25.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$25.8M
| Company | Shares | Value |
|---|---|---|
| ELVElevance Health Inc. | 58,100 | $17.0M |
| TLXTelix Pharmaceuticals Limited | 266,200 | $2.5M |
| LNTHLantheus Holdings, Inc. | 18,000 | $1.4M |
| LLYELI LILLY & Co | 1,458 | $1.3M |
| ONCBeOne Medicines Ltd. | 3,000 | $891K |
| OLMAOlema Pharmaceuticals, Inc. | 50,000 | $746K |
| REGNREGENERON PHARMACEUTICALS, INC. | 654 | $505K |
| IOVAIOVANCE BIOTHERAPEUTICS, INC. | 130,000 | $456K |
| ICLRICON plc | 3,000 | $332K |
| NUVLNuvalent, Inc. | 2,000 | $205K |
| ARVNARVINAS, INC. | 14,000 | $148K |
| SDGRSchrodinger, Inc. | 10,000 | $114K |
| RLAYRelay Therapeutics, Inc. | 10,000 | $100K |
| BCYCBICYCLE THERAPEUTICS PLC | 15,000 | $70K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.